Tuesday, 6 November 2018

Isreali Biochemists Produce anti-HIV drug that kills 99% of viruses

A new HIV drug, created by Israeli researchers, has passed its first clinical trial.

At the end of the trial, it was discovered that the drug called Gammora, created by Zion Medical, was an Israeli biotechnology company that was able to eliminate 99% of HIV-infected cells in the human body.

According to a statement released by the company and available on PR Newswire, Gammora could eliminate up to 90% of the virus in the first four weeks of the trial.

Zion Medical has developed the drug Gammora in collaboration with the Hebrew University of Jerusalem and Sirion Biotech in Germany.

The drug is designed to attack and kill HIV-infected cells in the human body without causing damage to healthy cells.

As part of this study, researchers randomly assigned 9 participating patients from Ronald Bata Memorial Hospital in Uganda to receive different doses of Gammora between four and five weeks in July and August of this year.

While the new anti-HIV drug is still in its first phase of exploration, the results already give hope of finding a cure for the dreaded virus.

"Most patients experienced a significant reduction in viral load of up to 90% from baseline in the first four weeks," said Dr. Esmira Naftalim, Zion Medical Development Manager.

No comments:

Post a Comment